22 related articles for article (PubMed ID: 31688624)
1. Infantile mediastinal neuroblastoma presenting as an oncologic emergency: usefulness of serum-based
Suematsu M; Yagyu S; Hosoi H; Iehara T
BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34972781
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Metastasis of Low-risk Perinatal Neuroblastoma After Resection: Implications for Surveillance.
Ullrich SJ; Worhunsky D; Rodwin R; Pashankar F; Christison-Lagay E; Ozgediz D
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e184-e186. PubMed ID: 31815890
[TBL] [Abstract][Full Text] [Related]
3. Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapy.
Yanishevski D; McCarville MB; Doubrovin M; Spiegl HR; Zhao X; Lu Z; Federico SM; Furman WL; Murphy AJ; Davidoff AM
J Pediatr Surg; 2020 Jan; 55(1):130-134. PubMed ID: 31685267
[TBL] [Abstract][Full Text] [Related]
4. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
[TBL] [Abstract][Full Text] [Related]
5. Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival.
Bomken S; Davies B; Chong L; Cole M; Wood KM; McDermott M; Tweddle DA
Pediatr Hematol Oncol; 2011 Mar; 28(2):106-14. PubMed ID: 21214410
[TBL] [Abstract][Full Text] [Related]
6. Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.
Twist CJ; Naranjo A; Schmidt ML; Tenney SC; Cohn SL; Meany HJ; Mattei P; Adkins ES; Shimada H; London WB; Park JR; Matthay KK; Maris JM
J Clin Oncol; 2019 Jan; 37(2):115-124. PubMed ID: 30444686
[TBL] [Abstract][Full Text] [Related]
7. Favorable histology, MYCN-amplified 4S neonatal neuroblastoma.
Chan EL; Harris RE; Emery KH; Gelfand MJ; Collins MH; Gruppo RA
Pediatr Blood Cancer; 2007 Apr; 48(4):479-82. PubMed ID: 16333837
[TBL] [Abstract][Full Text] [Related]
8. Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.
Ahmed AA; Zhang L; Reddivalla N; Hetherington M
Pediatr Hematol Oncol; 2017 Apr; 34(3):165-185. PubMed ID: 28662353
[TBL] [Abstract][Full Text] [Related]
9. Two hits are better than one: rational dual strategy efficiently fights neuroblastoma.
Zimmer J; Rolin C; Ollert M
Signal Transduct Target Ther; 2024 Apr; 9(1):116. PubMed ID: 38688910
[No Abstract] [Full Text] [Related]
10. Primary Pancreatic Neuroblastoma in an Infant.
Morrison ZD; Sun Y; Manalang M; Dominguez K
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e541-e543. PubMed ID: 31688624
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
